GE HealthCare, Mayo Clinic Partner on Personalized Radiation Therapy, Cancer Care

GE HealthCare and Mayo Clinic revealed their GEMINI-RT joint initiative in radiation therapy, which aims to transform personalized radiation therapy and cancer care.

The initiative builds on decades of partnership and the original Strategic Radiology Research Collaboration signed in 2023. GEMINI-RT expects to drive innovation in prediction, planning, automation, workflow and monitoring for radiation oncology.

It combines Mayo Clinic’s clinical and research expertise with GE HealthCare’s technical and engineering innovation in oncology care and radiation therapy. The initiative expects to provide personalized care by exploring integrating imaging, advanced therapies, dosimetry, and patient monitoring from detection and diagnosis to treatment and follow-up.

The duo will collaborated on artificial intelligence (AI)-powered solutions that can eliminate repetitive tasks and speed treatment planning. They will harness clinical insights to personalize cancer treatment decisions and improve outcomes by exploring approaches that merge radiation with emerging treatments like targeted drugs and precision heating.

They hope to provide connected care using AI, biomarkers, and sensors to monitor patients beyond the clinic, with the goal of predicting side effects early and supporting home treatment.

“GEMINI-RT is grounded in the concept of ‘twinning the patient, personalizing the beam’—a transformative approach made possible by Mayo Clinic’s extensive clinical expertise and outcomes data,” said Bryan Traughber, M.D., vice chair, innovation for radiation oncology, Mayo Clinic. “The combination of research and technological acumen could allow us to model individual patient journeys with precision, enabling radiation therapy treatments that are truly tailored to each patient.”

GEMINI-RT research and activities will be based at Mayo Clinic’s campus in Rochester, Minnesota, leveraging both organizations’ strengths in clinical practice, research, and product development.

“This effort enables us to collaborate on solutions that are not only leading-edge but also clinically meaningful, helping shape the future of personalized radiation therapy,” said Dr. Ben Newton, global head of Oncology at GE Healthcare. “By integrating innovative technology and AI across the care continuum, we can improve clinician experience, support high-quality patient care, and help reduce burnout among care teams.”

Earlier this week, the company showcased a variety of transformative radiological innovations at the RSNA 2025 annual meeting.